Roux-en-Y Gastric Bypass for BMI 27-32 Type 2 Diabetes Versus Best Medical Treatment

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2014
Investigators aim to show that Roux-en-Y Gastric Bypass (RYGB) is superior to best medical treatment in reaching well-defined treatment end points in Asian subjects of BMI 27-32 with type 2 Diabetes (DM2). Investigators also hope to show that successful RYGB will reduce resource utilization in the near term with similar projected reduction over the medium to long term.
Epistemonikos ID: 66b5b796e5abb229627a4e719d88b5bc082b8862
First added on: May 11, 2024